Onward Medical N.V. (EBR:ONWD)
3.460
-0.045 (-1.28%)
At close: Mar 20, 2026
Onward Medical Market Cap
Onward Medical has a market cap or net worth of €193.79 million as of March 20, 2026. Its market cap has decreased by -10.32% in one year.
Market Cap
193.79M
Enterprise Value
167.92M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.46
Market Cap Chart
Since October 21, 2021, Onward Medical's market cap has decreased from 379.67M to 193.79M, a decrease of -48.96%. That is a compound annual growth rate of -14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 193.79M | -3.31% |
| Dec 31, 2025 | 200.42M | -13.31% |
| Dec 31, 2024 | 231.18M | 147.06% |
| Dec 29, 2023 | 93.57M | -50.16% |
| Dec 30, 2022 | 187.75M | -39.02% |
| Dec 31, 2021 | 307.88M | -18.91% |
| Oct 21, 2021 | 379.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 47.97B |
| argenx SE | 36.82B |
| Financière de Tubize | 9.41B |
| Hyloris Pharmaceuticals | 157.36M |
| European Medical Solutions | 20.74M |
| Celyad Oncology | 14.06M |
| BioSenic | 1.50M |
| Oxurion NV | 392.55K |